NCT01753921

Brief Summary

This is a research study to understand how diabetic ketoacidosis may affect the brain and learning and to see if these changes are transient or permanent. The investigators hope to learn more about how diabetic ketoacidosis may cause changes in brain compliance (by wearing a non-invasive head band/helmet like device from Jan Medical: The Nautilus Neurowave System™ (NNS), learning, talking, behavior, or development. The investigators will compare those results from those with diabetes mellitus to those age and gendered matched healthy controls. Possible subjects in this study have diabetes mellitus and are between the ages of 10 to less than 17 years old OR do NOT have diabetes and are between the ages of 10 to less than 17 years old.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2012

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 20, 2012

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

November 13, 2019

Status Verified

November 1, 2019

Enrollment Period

4.9 years

First QC Date

September 18, 2012

Last Update Submit

November 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Unique signal measured in Hertz

    We will be using the brain compliance measurement device to see if there is a unique signal for those with DKA and if so, follow the duration of this signal.

    3 months

Study Arms (2)

DKA Group

Subjects who presented in diabetic ketoacidosis.

Other: this is not an intervention studyDevice: MRI

Healthy control

Control subjects without diabetes.

Other: this is not an intervention studyDevice: MRI

Interventions

Subjects will wear the headband/helmet-like device for approximately 10 minutes on four different occasions: t=0, t=1week, t=1month, t=3months. Of note, part of the device also involves electrodes that are worn to obtain an electrocardiogram or EKG.

DKA GroupHealthy control
MRIDEVICE

MRI study of the brain will be performed at t=3months.

DKA GroupHealthy control

Eligibility Criteria

Age10 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children between 10-16 with DKA

You may qualify if:

  • To be eligible for the study, all subjects must meet the following criteria:
  • Healthy control OR
  • Clinical new onset or established diagnosis of diabetes with diabetes ketoacidosis as defined by the Pediatric Endocrine Society Consensus Statement guidelines
  • Age 10 years to less than 17 years
  • Parent/guardian understand the study protocol and agrees to comply with it.
  • Primary care giver (i.e parent/guardian) comprehends written English. This is due to the fact that questionnaires and neurocognitive testing tools used as outcome measures do not have validated versions in Spanish or other language. Subject comprehends and speaks English.

You may not qualify if:

  • Subjects who meet any of the following criteria are not eligible for the study:
  • History of head trauma with any loss of consciousness
  • History of premature birth (less than 30 weeks of gestation)
  • History of significant developmental delay (lack of single word speech or ability to walk independently by 18 months of age
  • History of neurologic disease independent of diabetes (seizure disorder)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

Related Links

MeSH Terms

Conditions

Diabetes MellitusDiabetic Ketoacidosis

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesKetosisAcidosisAcid-Base ImbalanceDiabetes Complications

Study Officials

  • Tandy Aye, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 18, 2012

First Posted

December 20, 2012

Study Start

November 1, 2011

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

November 13, 2019

Record last verified: 2019-11

Locations